Dr Jeffrey Alan Michelson, MD | |
801 Mccarthy Blvd, New Bern, NC 28562-5237 | |
(252) 633-3942 | |
(252) 633-3332 |
Full Name | Dr Jeffrey Alan Michelson |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 801 Mccarthy Blvd, New Bern, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689668295 | NPI | - | NPPES |
891223X | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 9900613 (North Carolina) | Primary |
Entity Name | Eastern Carolina Womens Center Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962458265 PECOS PAC ID: 0446341010 Enrollment ID: O20070810000553 |
News Archive
HTDS www.htdsmedical.com - The Company intends to release its next 90 to 180 day forward guidance concurrent with its profile launch on www.stockprofile.com .
The scientific and medical community mourns the loss of our esteemed colleague and good friend Emeritus Professor James Boyer Brown AM, MSc (NZ), PhD (Edin), MSc (Melb), DSc (Edin), FRANZCOG (Ad Eundem), Life Member Fertility Society of Australia, Life Member Endocrine Society of Australia, who passed away on Saturday 31st October 2009, aged 90.
Vitamin E has been shown effective in treating nonalcoholic steatohepatitis, an obesity-associated chronic liver disease that can lead to cirrhosis, liver cancer, and death. NASH also is related to or a part of type 2 diabetes, lipid disorders and cardiovascular disease.
The Leapfrog Group's annual list of Top Hospitals was announced on December 4th in Baltimore, Maryland and included Boston Medical Center in Boston, MA for the first time. The announcement came at Leapfrog's Annual Meeting, focusing on transparency as the key to improved hospital safety, and Top Hospital Awards.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey Alan Michelson, MD 801 Mccarthy Blvd, New Bern, NC 28562-5237 Ph: (252) 633-3942 | Dr Jeffrey Alan Michelson, MD 801 Mccarthy Blvd, New Bern, NC 28562-5237 Ph: (252) 633-3942 |
News Archive
HTDS www.htdsmedical.com - The Company intends to release its next 90 to 180 day forward guidance concurrent with its profile launch on www.stockprofile.com .
The scientific and medical community mourns the loss of our esteemed colleague and good friend Emeritus Professor James Boyer Brown AM, MSc (NZ), PhD (Edin), MSc (Melb), DSc (Edin), FRANZCOG (Ad Eundem), Life Member Fertility Society of Australia, Life Member Endocrine Society of Australia, who passed away on Saturday 31st October 2009, aged 90.
Vitamin E has been shown effective in treating nonalcoholic steatohepatitis, an obesity-associated chronic liver disease that can lead to cirrhosis, liver cancer, and death. NASH also is related to or a part of type 2 diabetes, lipid disorders and cardiovascular disease.
The Leapfrog Group's annual list of Top Hospitals was announced on December 4th in Baltimore, Maryland and included Boston Medical Center in Boston, MA for the first time. The announcement came at Leapfrog's Annual Meeting, focusing on transparency as the key to improved hospital safety, and Top Hospital Awards.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
› Verified 6 days ago
Dr. Rolvix Harlan Patterson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 Fax: 252-633-3332 | |
Dr. Chris Elizabeth Morgan, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 Fax: 252-633-3332 | |
Paige Davis Clark, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 Fax: 252-633-3332 | |
Dr. Charles Lawrence Parker, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 | |
Dr. Ronnie Stephen Joyner, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 Fax: 252-633-3332 | |
Kristi Lynne English Brown, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 Fax: 252-633-3332 | |
Jennie Michelina Gillespie, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 Fax: 252-633-3332 |